McCormick & Co Inc: Form 10-K for the period ended Nov 30, 2023
Filed with the SEC on Jan 25, 2024 and accepted by EDGAR at Jan 25, 2024, 16:25 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-11-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-12-01 to 2023-11-30 | $6.66bn | us-gaap:Revenues |
| Cost of revenue | 12 months2022-12-01 to 2023-11-30 | $4.16bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2022-12-01 to 2023-11-30 | $2.50bn | us-gaap:GrossProfit |
| Research and development | 12 months2022-12-01 to 2023-11-30 | $94.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2022-12-01 to 2023-11-30 | $1.48bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2022-12-01 to 2023-11-30 | $963.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2022-12-01 to 2023-11-30 | $208.2m | us-gaap:InterestExpense |
| Income tax | 12 months2022-12-01 to 2023-11-30 | $174.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-12-01 to 2023-11-30 | $680.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-12-01 to 2023-11-30 | $2.52 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-12-01 to 2023-11-30 | $2.54 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-12-01 to 2023-11-30 | 269,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-12-01 to 2023-11-30 | $1.24bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-12-01 to 2023-11-30 | $263.9m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 12 months2022-12-01 to 2023-11-30 | $418.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2022-12-01 to 2023-11-30 | $35.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-11-30 | $166.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-11-30 | $2.00bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-11-30 | $12.86bn | us-gaap:Assets |
| Current liabilities | At period end2023-11-30 | $3.10bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-11-30 | $7.78bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-11-30 | $3.34bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-11-30 | $799.3m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2023-11-30 | $272.2m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-11-30 | $5.06bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000063754-24-000027. Last ingested by Listed: Nov 5, 2026, 13:15 ET. Listed shows no prices and gives no investment advice.